title: [Local catheter-mediated lysis of the femoral artery: rt-PA versus urokinase].
abstract: Percutaneous, catheter-mediated lysis was performed on 56 patients with acute to subacute thrombosis of the superficial femoral artery (Fontaine stage IIb to IV). One half of the patients received rt-PA, the other half urokinase. The clinical parameters of the two groups of patients were largely the same. The therapeutical results were, at about the same treatment costs, better in the rt-PA patients group, in particular with regard to the considerably shorter average treatment period, which lasted on the average for 2 hours in the rt-PA group, vs. 6 hours in the urokinase group. The recanalisation rate was also higher in the rt-PA group (86%) vs. 75% in the urokinase group.
authors.affiliation: Radiologische Abteilung, Krankenanstalten des Zollernalbkreises am Kreiskrankenhaus Albstadt.
authors.forename: F J
authors.initials: FJ
authors.lastname: Krause
authors.forename: O
authors.initials: O
authors.lastname: Endsin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002406:Catheterization, Peripheral / Q000379:methods; D004341:Drug Evaluation; D005263:Femoral Artery / Q000000981:diagnostic imaging; D006801:Humans; D008875:Middle Aged; D011150:Popliteal Artery / Q000000981:diagnostic imaging; D015641:Radiography, Interventional; D011994:Recombinant Proteins / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods*; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator